Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers

Sijin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Lanzhou University), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(Army Medical University), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengwei Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Guochao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Lv(Liaoning Normal University), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Renda Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Molecular Biosciences
March 12, 2021
10.3389/fmolb.2021.587436
Cited by 20

Related Papers

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding
|Nature Communications|2021|193
WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis
|Cell Death and Disease|2021|171
PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
|Journal of Hematology & Oncology|2018|162